Takeda Pharmaceutical annual capital expenditures (capex)
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Takeda Pharmaceutical Capital Expenditures (CapEx) Growth & History (TAK)
Takeda Pharmaceutical's capital expenditures (capex) was ¥414.66B for fiscal 2026.
View full Takeda Pharmaceutical company overviewTakeda Pharmaceutical annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | ¥414.66B | ¥213.86B | +106.51% |
| 2025 | 2025-03-31 | ¥200.79B | ¥25.38B | +14.47% |
| 2024 | 2024-03-31 | ¥175.42B | ¥34.76B | +24.71% |
| 2023 | 2023-03-31 | ¥140.66B | ¥17.41B | +14.12% |
| 2022 | 2022-03-31 | ¥123.25B | ¥12.05B | +10.83% |
| 2021 | 2021-03-31 | ¥111.21B | −¥15.88B | −12.49% |
| 2020 | 2020-03-31 | ¥127.08B | ¥49.41B | +63.60% |
| 2019 | 2019-03-31 | ¥77.68B | ¥10.67B | +15.93% |
| 2018 | 2018-03-31 | ¥67.00B | ¥5.34B | +8.67% |
| 2017 | 2017-03-31 | ¥61.66B | — | — |
Takeda Pharmaceutical quarterly capital expenditures (capex)
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-03-31 | ¥64.39B | −¥28.33B | −30.55% |
| Q3 2026 | 2025-12-31 | ¥222.37B | — | — |
| Q2 2026 | 2025-09-30 | ¥52.83B | — | — |
| Q1 2026 | 2025-06-30 | ¥75.07B | — | — |
| Q4 2025 | 2025-03-31 | ¥92.72B | — | — |
Takeda Pharmaceutical capital expenditures (capex) trends
Over the last five fiscal years, Takeda Pharmaceutical's capital expenditures (capex) increased from ¥111.21B to ¥414.66B, a change of ¥303.45B. The latest reported quarter, Q4 2026, shows ¥64.39B.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Takeda Pharmaceutical source filings ↗